Cargando…

Host defence peptides identified in human apolipoprotein B as promising antifungal agents

ABSTRACT: Therapeutic options to treat invasive fungal infections are still limited. This makes the development of novel antifungal agents highly desirable. Naturally occurring antifungal peptides represent valid candidates, since they are not harmful for human cells and are endowed with a wide rang...

Descripción completa

Detalles Bibliográficos
Autores principales: Dell’Olmo, Eliana, Gaglione, Rosa, Cesaro, Angela, Cafaro, Valeria, Teertstra, Wieke R., de Cock, Hans, Notomista, Eugenio, Haagsman, Henk P., Veldhuizen, Edwin J. A., Arciello, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907042/
https://www.ncbi.nlm.nih.gov/pubmed/33576886
http://dx.doi.org/10.1007/s00253-021-11114-3
_version_ 1783655412975796224
author Dell’Olmo, Eliana
Gaglione, Rosa
Cesaro, Angela
Cafaro, Valeria
Teertstra, Wieke R.
de Cock, Hans
Notomista, Eugenio
Haagsman, Henk P.
Veldhuizen, Edwin J. A.
Arciello, Angela
author_facet Dell’Olmo, Eliana
Gaglione, Rosa
Cesaro, Angela
Cafaro, Valeria
Teertstra, Wieke R.
de Cock, Hans
Notomista, Eugenio
Haagsman, Henk P.
Veldhuizen, Edwin J. A.
Arciello, Angela
author_sort Dell’Olmo, Eliana
collection PubMed
description ABSTRACT: Therapeutic options to treat invasive fungal infections are still limited. This makes the development of novel antifungal agents highly desirable. Naturally occurring antifungal peptides represent valid candidates, since they are not harmful for human cells and are endowed with a wide range of activities and their mechanism of action is different from that of conventional antifungal drugs. Here, we characterized for the first time the antifungal properties of novel peptides identified in human apolipoprotein B. ApoB-derived peptides, here named r(P)ApoB(L)(Pro), r(P)ApoB(L)(Ala) and r(P)ApoB(S)(Pro), were found to have significant fungicidal activity towards Candida albicans (C. albicans) cells. Peptides were also found to be able to slow down metabolic activity of Aspergillus niger (A. niger) spores. In addition, experiments were carried out to clarify the mechanism of fungicidal activity of ApoB-derived peptides. Peptides immediately interacted with C. albicans cell surfaces, as indicated by fluorescence live cell imaging analyses, and induced severe membrane damage, as indicated by propidium iodide uptake induced upon treatment of C. albicans cells with ApoB-derived peptides. ApoB-derived peptides were also tested on A. niger swollen spores, initial hyphae and branched mycelium. The effects of peptides were found to be more severe on swollen spores and initial hyphae compared to mycelium. Fluorescence live cell imaging analyses confirmed peptide internalization into swollen spores with a consequent accumulation into hyphae. Altogether, these findings open interesting perspectives to the application of ApoB-derived peptides as effective antifungal agents. KEY POINTS: Human cryptides identified in ApoB are effective antifungal agents. ApoB-derived cryptides exert fungicidal effects towards C. albicans cells. ApoB-derived cryptides affect different stages of growth of A. niger. Graphical abstract [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11114-3.
format Online
Article
Text
id pubmed-7907042
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-79070422021-03-09 Host defence peptides identified in human apolipoprotein B as promising antifungal agents Dell’Olmo, Eliana Gaglione, Rosa Cesaro, Angela Cafaro, Valeria Teertstra, Wieke R. de Cock, Hans Notomista, Eugenio Haagsman, Henk P. Veldhuizen, Edwin J. A. Arciello, Angela Appl Microbiol Biotechnol Biotechnologically Relevant Enzymes and Proteins ABSTRACT: Therapeutic options to treat invasive fungal infections are still limited. This makes the development of novel antifungal agents highly desirable. Naturally occurring antifungal peptides represent valid candidates, since they are not harmful for human cells and are endowed with a wide range of activities and their mechanism of action is different from that of conventional antifungal drugs. Here, we characterized for the first time the antifungal properties of novel peptides identified in human apolipoprotein B. ApoB-derived peptides, here named r(P)ApoB(L)(Pro), r(P)ApoB(L)(Ala) and r(P)ApoB(S)(Pro), were found to have significant fungicidal activity towards Candida albicans (C. albicans) cells. Peptides were also found to be able to slow down metabolic activity of Aspergillus niger (A. niger) spores. In addition, experiments were carried out to clarify the mechanism of fungicidal activity of ApoB-derived peptides. Peptides immediately interacted with C. albicans cell surfaces, as indicated by fluorescence live cell imaging analyses, and induced severe membrane damage, as indicated by propidium iodide uptake induced upon treatment of C. albicans cells with ApoB-derived peptides. ApoB-derived peptides were also tested on A. niger swollen spores, initial hyphae and branched mycelium. The effects of peptides were found to be more severe on swollen spores and initial hyphae compared to mycelium. Fluorescence live cell imaging analyses confirmed peptide internalization into swollen spores with a consequent accumulation into hyphae. Altogether, these findings open interesting perspectives to the application of ApoB-derived peptides as effective antifungal agents. KEY POINTS: Human cryptides identified in ApoB are effective antifungal agents. ApoB-derived cryptides exert fungicidal effects towards C. albicans cells. ApoB-derived cryptides affect different stages of growth of A. niger. Graphical abstract [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11114-3. Springer Berlin Heidelberg 2021-02-12 2021 /pmc/articles/PMC7907042/ /pubmed/33576886 http://dx.doi.org/10.1007/s00253-021-11114-3 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Biotechnologically Relevant Enzymes and Proteins
Dell’Olmo, Eliana
Gaglione, Rosa
Cesaro, Angela
Cafaro, Valeria
Teertstra, Wieke R.
de Cock, Hans
Notomista, Eugenio
Haagsman, Henk P.
Veldhuizen, Edwin J. A.
Arciello, Angela
Host defence peptides identified in human apolipoprotein B as promising antifungal agents
title Host defence peptides identified in human apolipoprotein B as promising antifungal agents
title_full Host defence peptides identified in human apolipoprotein B as promising antifungal agents
title_fullStr Host defence peptides identified in human apolipoprotein B as promising antifungal agents
title_full_unstemmed Host defence peptides identified in human apolipoprotein B as promising antifungal agents
title_short Host defence peptides identified in human apolipoprotein B as promising antifungal agents
title_sort host defence peptides identified in human apolipoprotein b as promising antifungal agents
topic Biotechnologically Relevant Enzymes and Proteins
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907042/
https://www.ncbi.nlm.nih.gov/pubmed/33576886
http://dx.doi.org/10.1007/s00253-021-11114-3
work_keys_str_mv AT dellolmoeliana hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT gaglionerosa hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT cesaroangela hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT cafarovaleria hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT teertstrawieker hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT decockhans hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT notomistaeugenio hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT haagsmanhenkp hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT veldhuizenedwinja hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents
AT arcielloangela hostdefencepeptidesidentifiedinhumanapolipoproteinbaspromisingantifungalagents